Is this a real IVF or fertility clinic case study?

No. This is a simulated proof-of-method asset built with synthetic workflow rows. It is not a real clinic, doctor, embryologist, nurse, counsellor, patient, partner, donor, PHI, personal data, production export, client result, testimonial, logo, certification, platform partnership, DPDP compliance claim, medical advice, legal advice, privacy advice, security advice, fertility outcome claim, pregnancy outcome claim, appointment-growth claim, no-show reduction, payment approval improvement, revenue claim, ROI claim, ranking claim, demand claim, lead claim or AI-accuracy claim.

What operational problem does it demonstrate?

It demonstrates how IVF package enquiries, first-consult bookings, scan reminders, stimulation and injection questions, beta-hCG callbacks, embryo-grading questions, donor-programme privacy questions, finance blockers and old-patient recalls can be separated into admin-safe follow-up, clinical or embryologist review, consent gaps, owner-ageing queues and next-safe-action rules.

Simulated proof asset · India IVF/fertility · follow-up + DPDP-aware evidence

Simulated India IVF/fertility follow-up DPDP diagnostic

Q: Can this guarantee DPDP compliance, clinical outcomes, appointment growth or revenue?

No. The figures are synthetic arithmetic outputs only. A real pilot would require permissioned and minimised operational data, qualified medical, legal, privacy and security review, and explicit clinic approval before any public patient, DPDP, clinical, appointment, no-show, finance, revenue or ROI statement.

This no-fake-client proof asset shows how AICS can inspect workflow leakage around IVF package enquiries, first-consult bookings, follicular-scan reminders, stimulation questions, beta-hCG callbacks, embryo-grading updates, donor-programme privacy questions, finance-document follow-up and old-patient recall. It is synthetic only: no real fertility clinic, no real doctor, no real embryologist, no real patient, no PHI, no customer data, no production export, no DPDP compliance claim, no fertility outcome, no pregnancy outcome, no appointment lift, no payment approval lift, no revenue or ROI claim is made.

Request an IVF workflow fit check Explore Healthcare GrowthOS Back to proof hub

Important claim boundary: this page is a simulated proof-of-method demonstration. It is not a customer case study, not a testimonial, not a customer-data analysis, and makes no real clinic, no real doctor, no real embryologist, no real patient, no PHI, no medical advice, no legal advice, no privacy advice, no security advice, no DPDP compliance claim, no fertility outcome claim, no pregnancy outcome claim, no appointment growth, no no-show reduction, no payment approval improvement, no ranking, no revenue and no ROI promise.

Synthetic rows12IVF/fertility workflow sample

Monthly items represented1,053synthetic volume only

Callback coverage68.2%source-log synthetic arithmetic

Admin-safe rows4after consent and clinical checks

IVF cycle-stage logging100.0%synthetic follow-up evidence

Lab/scan logging81.9%synthetic follow-up evidence

Consent-not-ready rows6notice/opt-in/boundary gaps

Human-review rows8clinical or embryology routing

Diagnostic method

What a fertility-clinic owner can inspect before buying another reminder bot or AI receptionist

The diagnostic converts IVF and fertility follow-up rows into operating queues: source, owner, consent notice, WhatsApp opt-in, AI/admin boundary disclosure, queue age, clinical or embryologist review, finance blocker, closure gap and next safe action.

Evidence/control area	Synthetic volume or state	Why AICS would flag it
Admin-safe follow-up	4 candidates	Only consult booking, scan-reminder, finance-document and recall logistics with consent and no clinical question should move toward automation.
Clinical/embryologist-review boundary	8 rows	Treatment choice, stimulation/injection timing, beta-hCG interpretation, embryo-grading, donor privacy and post-retrieval symptoms require qualified human review.
Urgent/red-flag route	2 rows	Beta-hCG red-flag language or post-retrieval pain/bleeding cannot be handled as generic follow-up automation.
Owner ageing	5 rows idle for 24h+	Clinic owners need named owner, queue age and next-safe-action visibility before judging staffing or automation.
Consent and boundary readiness	6 rows not ready	WhatsApp, call, SMS or AI-assisted admin follow-up needs consent, notice and boundary evidence reviewed with appropriate advisers.
Closure evidence	9 rows with closure gaps	A queue should not be called resolved until reason, owner and next-safe-action evidence is captured.

Before diagnostic

Package enquiries, scans, lab callbacks, embryo updates, finance documents and old-patient recalls sit in one blended list.
Notice, WhatsApp opt-in, owner ageing, clinical/embryology boundary and escalation evidence are easy to miss.
Automation decisions risk sending unsafe fertility, lab-result or treatment-context communication.

After diagnostic operating rule

Each row has queue type, owner role, ageing, evidence gap and next safe action.
Stimulation, beta-hCG, embryo-grading, donor privacy and red-flag symptom rows route to qualified human review before automation.
The result is an owner action backlog, not a DPDP certificate, fertility outcome claim or revenue promise.

Evidence needed before publishing any real IVF/fertility outcome

A real pilot should request only permissioned, minimized and redacted operational exports; define source, owner, consent notice, WhatsApp opt-in, boundary disclosure, queue age, blocker, escalation and next-safe-action fields; and obtain explicit clinic approval plus qualified medical, legal, privacy and security review before any public patient, DPDP, fertility, pregnancy, appointment, no-show, payment, revenue or ROI statement.

Synthetic data only
No patient or PHI data
No medical advice
No DPDP compliance claim
No revenue or ROI claim

Request IVF workflow fit check Explore Healthcare GrowthOS

Reproducibility

Internal synthetic artifact: /home/agent/.hermes/aicloudstrategist/case-studies/simulated-india-ivf-fertility-followup-dpdp-2026-08-28/. Expected headline output: rows=12, synthetic_monthly_items=1053, callback_coverage_pct=68.2, ivf_cycle_followup_logging_pct=100.0, lab_scan_followup_logging_pct=81.9, consent_boundary_not_ready_rows=6, owner_gap_rows=4, stale_24h_rows=5, human_review_rows=8, red_flag_rows=2, payment_or_finance_blocker_rows=1, closure_gap_rows=9, admin_safe_rows=4. Input SHA256 8f62a39528da4b1268b79a0230fa69e3850f97841c7c562a7a9219f21b580e42; generator SHA256 e8cd36871c3eff2286548f8f7d019e01e2914d4a8e7ffc7178fc211d94b8f8d5; report SHA256 322db18d688ccc35e177bc41ed4253eaa000a7afee915a0eabe6bbb3bf8a6afe.

More proof assets · Healthcare GrowthOS · Clinic/lab DPDP WhatsApp evidence checklist